Â鶹´«Ã½

$459.9 Million
Arvinas
Follow-On Offering
Active Bookrunner
$92.1 Million
Ocular Therapeutix, Inc.
Follow-On Offering
Active Bookrunner
$208.0 Million
ALX Oncology
Follow-On Offering
Active Bookrunner
$299.0 Million
Rocket Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$145.0 Million
Sutro Biopharma, Inc.
Follow-On Offering
Active Bookrunner
$115.0 Million
Cogent Biosciences
Follow-On Offering
Active Bookrunner
$115.0 Million
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$149.5 Million
Keros Therapeutics
Follow-On Offering
Active Bookrunner
$48.3 Million
Aptinyx Inc.
Follow-On Offering
Active Bookrunner
$203.9 Million
I-Mab Biopharma
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2026 Â鶹´«Ã½. Since 1895. All rights reserved.